![](https://www.raskmedia.com.au/wp-content/uploads/2024/02/Pro-Medicus-share-price-PME-Apple-Vision-Pro.jpg)
Pro Medicus (ASX:PME) share price jumps on Apple Vision Pro update
The Pro Medicus Ltd (ASX:PME) share price has gone up 4% after the ASX healthcare share revealed Visage Ease VP for Apple Vision Pro.
Looking for growth in 2020 and beyond? Here are the latest ASX growth stock ideas, stories and news from our team at Rask Media. We think it’s fair to say that Australia’s ASX growth stocks are some of the best in the world, given their potential for international growth and the fact that many Australian companies also offer their dividends with franking credits.
The Pro Medicus Ltd (ASX:PME) share price has gone up 4% after the ASX healthcare share revealed Visage Ease VP for Apple Vision Pro.
Here’s the market update for both the US and Australian share markets by David Bassanese of Betashares. Both the S&P 500 (INDEXSP: .INX) and the S&P/ASX 200 (INDEXASX: XJO) are on a new record high.
The Johns Lyng Group Ltd (ASX:JLG) share price is up 2% after the rebuilding and restoration business revealed a strong US update.
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished up +1.47% to 7,699.40.
The S&P/ASX 200 (INDEXASX: XJO) Index could not hold on to yesterday’s record close, dropping 92.5 points, or 1.2 per cent, to 7,588.2 points, with all 11 industry sub-indices losing ground.
There are some wonderful ASX growth shares I’d want to buy in February. I’m going to tell you about two, including Xero Limited (ASX:XRO).
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished down -1.20% to 7,588.20.
A deep dive into ResMed Inc (ASX: RMD) shares and Magellan Financial Group Ltd (ASX: MFG) shares by Rask’s Chief Investment Officer, Owen Rask.
The benchmark S&P/ASX 200 (INDEXASX: XJO) closed up 80.5 points, or 1.1 per cent, to 7,680.7 – 51.8 points, or 0.7 per cent, above the previous closing record of 7,628.9 points, which was reached in August 2021. The broader All Ordinaries (INDEXASX: XAO) index added 77.8 points, or 1 per cent, to 7,912.8.
The Pro Medicus Ltd (ASX:PME) share price has gone up 4% after the ASX healthcare share revealed Visage Ease VP for Apple Vision Pro.
Here’s the market update for both the US and Australian share markets by David Bassanese of Betashares. Both the S&P 500 (INDEXSP: .INX) and the S&P/ASX 200 (INDEXASX: XJO) are on a new record high.
The Johns Lyng Group Ltd (ASX:JLG) share price is up 2% after the rebuilding and restoration business revealed a strong US update.
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished up +1.47% to 7,699.40.
The S&P/ASX 200 (INDEXASX: XJO) Index could not hold on to yesterday’s record close, dropping 92.5 points, or 1.2 per cent, to 7,588.2 points, with all 11 industry sub-indices losing ground.
There are some wonderful ASX growth shares I’d want to buy in February. I’m going to tell you about two, including Xero Limited (ASX:XRO).
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished down -1.20% to 7,588.20.
A deep dive into ResMed Inc (ASX: RMD) shares and Magellan Financial Group Ltd (ASX: MFG) shares by Rask’s Chief Investment Officer, Owen Rask.
The benchmark S&P/ASX 200 (INDEXASX: XJO) closed up 80.5 points, or 1.1 per cent, to 7,680.7 – 51.8 points, or 0.7 per cent, above the previous closing record of 7,628.9 points, which was reached in August 2021. The broader All Ordinaries (INDEXASX: XAO) index added 77.8 points, or 1 per cent, to 7,912.8.
Want to level-up your analytical skills and investing insights but don’t know where to start? We can help. Join 40,000+ Australian investors on our mailing list today and we’ll send you our favourite podcasts, courses, resources, investment articles and podcasts every week. Delivered to your inbox every Sunday morning. Grab a coffee and let Owen and the team bring you the best investment insights every week.